VIEMED HEALTHCARE, INC. Operating Cash Flow
VIEMED HEALTHCARE, INC. (VMD) reported Operating Cash Flow of $23.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $15.90M, a 29.77% increase year-over-year.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $8.07M, a 182.80% increase year-over-year.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $18.44M, a 23.05% increase year-over-year.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $18.37M, a 44.11% increase year-over-year.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for fiscal 2025 was $51.92M, a 32.81% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for fiscal 2024 was $39.09M, a 13.54% decline from fiscal 2023.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for fiscal 2023 was $45.21M, a 62.94% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. net cash provided by (used in) operating activities for fiscal 2022 was $27.75M, a 23.36% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $23.97M 10-Q · filed 2026-08-03 | $42.41M derived: sum of 3 quarters · filed 2026-08-03 | $60.78M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $8.07M 10-Q · filed 2026-05-05 | $26.51M derived: sum of 2 quarters · filed 2026-05-05 | $44.88M derived: sum of 3 quarters · filed 2026-05-05 | $57.13M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $18.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $36.81M derived: sum of 2 quarters · filed 2026-03-04 | $49.06M derived: sum of 3 quarters · filed 2026-08-03 | $51.92M 10-K · filed 2026-03-04 |
| 2025-09-30 | $18.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $30.62M derived: sum of 2 quarters · filed 2026-08-03 | $33.48M 10-Q · filed 2025-11-05 | $48.46M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $12.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $15.11M 10-Q · filed 2026-08-03 | $30.09M derived: sum of 3 quarters · filed 2026-08-03 | $42.84M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $2.85M 10-Q · filed 2026-05-05 | $17.84M derived: sum of 2 quarters · filed 2026-05-05 | $30.59M derived: sum of 3 quarters · filed 2026-05-05 | $40.77M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $14.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $27.73M derived: sum of 2 quarters · filed 2026-03-04 | $37.91M derived: sum of 3 quarters · filed 2026-03-04 | $39.09M 10-K · filed 2026-03-04 |
| 2024-09-30 | $12.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $22.93M derived: sum of 2 quarters · filed 2025-11-05 | $24.10M 10-Q · filed 2025-11-05 | $37.39M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | $10.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $11.36M 10-Q · filed 2025-08-06 | $24.64M derived: sum of 3 quarters · filed 2026-03-04 | $38.45M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $1.18M 10-Q · filed 2025-05-07 | $14.46M derived: sum of 2 quarters · filed 2026-03-04 | $28.27M derived: sum of 3 quarters · filed 2026-03-04 | $35.89M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $13.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $27.09M derived: sum of 2 quarters · filed 2026-03-04 | $34.72M derived: sum of 3 quarters · filed 2026-03-04 | $45.21M 10-K · filed 2026-03-04 |
| 2023-09-30 | $13.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $21.43M derived: sum of 2 quarters · filed 2024-11-06 | $31.93M 10-Q · filed 2024-11-06 | $39.61M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | $7.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $18.12M 10-Q · filed 2024-08-07 | $25.80M derived: sum of 3 quarters · filed 2025-03-10 | $33.77M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | $10.50M 10-Q · filed 2024-05-06 | $18.18M derived: sum of 2 quarters · filed 2025-03-10 | $26.15M derived: sum of 3 quarters · filed 2025-03-10 | $31.10M derived: sum of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | $7.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $15.66M derived: sum of 2 quarters · filed 2025-03-10 | $20.60M derived: sum of 3 quarters · filed 2025-03-10 | $27.75M 10-K · filed 2025-03-10 |
| 2022-09-30 | $7.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $12.92M derived: sum of 2 quarters · filed 2023-11-01 | $20.06M 10-Q · filed 2023-11-01 | $28.72M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $12.09M 10-Q · filed 2023-08-09 | $20.75M derived: sum of 3 quarters · filed 2023-08-09 | $25.77M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $7.15M 10-Q · filed 2023-05-08 | $15.80M derived: sum of 2 quarters · filed 2023-05-08 | $20.83M derived: sum of 3 quarters · filed 2023-05-08 | $25.01M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $8.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $13.68M derived: sum of 2 quarters · filed 2023-03-02 | $17.87M derived: sum of 3 quarters · filed 2023-03-02 | $22.49M 10-K · filed 2023-03-02 |
| 2021-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $9.21M derived: sum of 2 quarters · filed 2022-11-01 | $13.84M 10-Q · filed 2022-11-01 | $19.63M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $8.81M 10-Q · filed 2022-08-02 | $14.60M derived: sum of 3 quarters · filed 2022-08-02 | $21.93M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $4.63M 10-Q · filed 2022-05-03 | $10.42M derived: sum of 2 quarters · filed 2022-05-03 | $17.75M derived: sum of 3 quarters · filed 2022-05-03 | $39.13M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $13.12M derived: sum of 2 quarters · filed 2022-03-07 | $34.50M derived: sum of 3 quarters · filed 2022-03-07 | $35.11M 10-K · filed 2022-03-07 |
| 2020-09-30 | $7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $28.71M derived: sum of 2 quarters · filed 2021-11-02 | $29.32M 10-Q · filed 2021-11-02 | $36.72M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $21.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $21.99M 10-Q · filed 2021-08-03 | $29.39M derived: sum of 3 quarters · filed 2021-08-03 | $35.11M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $607.00K 10-Q · filed 2021-05-03 | $8.01M derived: sum of 2 quarters · filed 2021-05-03 | $13.73M derived: sum of 3 quarters · filed 2021-05-03 | $19.04M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $13.12M derived: sum of 2 quarters · filed 2021-03-03 | $18.44M derived: sum of 3 quarters · filed 2021-03-03 | $19.09M 10-K · filed 2021-03-03 |
| 2019-09-30 | $5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $11.04M derived: sum of 2 quarters · filed 2020-11-04 | $11.69M 10-Q · filed 2020-11-04 | $19.89M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $5.96M 10-Q · filed 2020-08-04 | $14.17M derived: sum of 3 quarters · filed 2020-08-04 | $19.33M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $650.00K 10-Q · filed 2020-05-05 | $8.86M derived: sum of 2 quarters · filed 2020-05-05 | $14.02M derived: sum of 3 quarters · filed 2020-05-05 | |
| 2018-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $13.37M derived: sum of 2 quarters · filed 2020-03-04 | $22.37M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $14.16M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $9.00M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |